Institute of Psychiatry and Neurology, Warsaw
10
6
6
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Effects of Neuronavigated Theta Burst Stimulation in Therapy of Post-stroke Aphasia
Role: lead
Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution
Role: collaborator
Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.
Role: collaborator
Polish Version Fatigue Severity Scale
Role: collaborator
Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression
Role: collaborator
Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
Role: lead
4FM Acceptance Training as the New Form of cPTSD-focused Treatment Based on Existential Analysis
Role: lead
Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize...
Role: collaborator
Smoking Cessation Interventions in Stroke Patients
Role: lead
Fatty Acids Omega -3 Diet Supplementation Efficiency and Safety Evaluation in Anorexia Nervosa
Role: lead
All 10 trials loaded